333 related articles for article (PubMed ID: 19720050)
1. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.
Czech B; Pfeilschifter W; Mazaheri-Omrani N; Strobel MA; Kahles T; Neumann-Haefelin T; Rami A; Huwiler A; Pfeilschifter J
Biochem Biophys Res Commun; 2009 Nov; 389(2):251-6. PubMed ID: 19720050
[TBL] [Abstract][Full Text] [Related]
2. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
[TBL] [Abstract][Full Text] [Related]
3. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
4. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
[TBL] [Abstract][Full Text] [Related]
5. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
6. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.
Pfeilschifter W; Czech-Zechmeister B; Sujak M; Mirceska A; Koch A; Rami A; Steinmetz H; Foerch C; Huwiler A; Pfeilschifter J
Biochem Biophys Res Commun; 2011 Sep; 413(2):212-7. PubMed ID: 21872577
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds.
Tölle M; Levkau B; Kleuser B; van der Giet M
Eur J Clin Invest; 2007 Mar; 37(3):171-9. PubMed ID: 17359484
[TBL] [Abstract][Full Text] [Related]
8. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2008 Apr; 210(2):681-90. PubMed ID: 18261728
[TBL] [Abstract][Full Text] [Related]
9. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
10. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration.
Kaudel CP; Frink M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; van Griensven M; Winkler M
Transplant Proc; 2007 Mar; 39(2):499-502. PubMed ID: 17362767
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis.
Liu HB; Cui NQ; Wang Q; Li DH; Xue XP
Pancreas; 2008 Apr; 36(3):e10-5. PubMed ID: 18362832
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod provides long-term protection in rodent models of cerebral ischemia.
Wei Y; Yemisci M; Kim HH; Yung LM; Shin HK; Hwang SK; Guo S; Qin T; Alsharif N; Brinkmann V; Liao JK; Lo EH; Waeber C
Ann Neurol; 2011 Jan; 69(1):119-29. PubMed ID: 21280082
[TBL] [Abstract][Full Text] [Related]
13. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.
Idzko M; Hammad H; van Nimwegen M; Kool M; Müller T; Soullié T; Willart MA; Hijdra D; Hoogsteden HC; Lambrecht BN
J Clin Invest; 2006 Nov; 116(11):2935-44. PubMed ID: 17080194
[TBL] [Abstract][Full Text] [Related]
14. [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Tar L; Vécsei L
Ideggyogy Sz; 2012 Mar; 65(3-4):83-100. PubMed ID: 23136726
[TBL] [Abstract][Full Text] [Related]
15. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice.
Kaudel CP; Schmiddem U; Frink M; Bergmann S; Pape HC; Krettek C; Klempnauer J; Winkler M
Transplant Proc; 2006 Apr; 38(3):679-81. PubMed ID: 16647442
[TBL] [Abstract][Full Text] [Related]
16. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
17. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
Dev KK; Mullershausen F; Mattes H; Kuhn RR; Bilbe G; Hoyer D; Mir A
Pharmacol Ther; 2008 Jan; 117(1):77-93. PubMed ID: 17961662
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.
Klingenberg R; Nofer JR; Rudling M; Bea F; Blessing E; Preusch M; Grone HJ; Katus HA; Hansson GK; Dengler TJ
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2392-9. PubMed ID: 17761943
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system-directed effects of FTY720 (fingolimod).
Miron VE; Schubart A; Antel JP
J Neurol Sci; 2008 Nov; 274(1-2):13-7. PubMed ID: 18678377
[TBL] [Abstract][Full Text] [Related]
20. FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model.
Kaudel CP; Frink M; van Griensven M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; Winkler M
Transplant Proc; 2007 Mar; 39(2):493-8. PubMed ID: 17362766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
